71 results
Page 3 of 4
8-K
EX-99.1
namlzy4u6e njbx
1 Mar 21
Results of Operations and Financial Condition
4:10pm
8-K
EX-99.1
g4vhlt5
12 Nov 20
Agile Therapeutics Reports Third Quarter 2020 Financial Results
4:10pm
8-K
EX-1.1
jatj3
21 Feb 20
Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
4:46pm
424B5
lun m1jsplzeew72n8
21 Feb 20
Prospectus supplement for primary offering
4:26pm
424B5
870jqnaw4rt
20 Feb 20
Prospectus supplement for primary offering
5:28pm
8-K
EX-10.1
0wg7va84
12 Feb 20
Entry into a Material Definitive Agreement
8:00am
8-K
EX-1.1
rgkbcg7 tr6o
8 Nov 19
Entry into a Material Definitive Agreement
4:38pm
424B5
lkrciau
8 Nov 19
Prospectus supplement for primary offering
4:34pm
8-K
EX-1.1
5n5nz8b08em7ozb3vd
2 Aug 19
Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
4:50pm
D
jhfjt
14 Mar 19
$7.84M in equity, sold $7.84M, 1 investor
2:44pm
8-K
EX-10.1
dpshwunpie07j4svw0
4 Mar 19
Agile Therapeutics Announces $7.8 Million Private Placement
5:27pm
8-K
EX-1.1
f8o7x8l83a1
23 Jan 19
Entry into a Material Definitive Agreement
8:04am